Creadev

Creadev is the long-term, evergreen investment vehicle of the Mulliez family, the founding family behind Auchan and a number of large French and European retail and consumer businesses. The firm operates from offices in Paris, Shanghai, and other geographies, investing patient capital across stages from growth equity to selective venture, with a thesis focused on long-term value creation in food and agriculture, health, services, and sustainable industries. For healthcare AI founders, Creadev is a real and meaningful potential investor at the growth-stage end, particularly Series B and later, where ticket sizes typically run from EUR 5M to EUR 30M or more. The firm is not a fit for seed or early Series A founders, who should look to specialist VCs first. The strongest fit is for healthcare AI companies with substantial revenue, meaningful European or Asian geographic exposure, and a thesis of long-duration compounding rather than fast exit. Founders building consumer health, value-based care services, food-and-health convergence plays, or healthcare delivery infrastructure with credible long-horizon economics will resonate; pure software founders with hyper-growth, short-hold expectations may find Creadev’s evergreen, family-office-style approach a mismatch. Entry path is through the firm’s website inquiry form or a referral from a portfolio CEO or Mulliez ecosystem operator. Expect commercial-heavy diligence, with emphasis on unit economics, defensibility, capital efficiency, and management quality rather than narrow technical or scientific milestones. Founders should be ready to discuss governance and minority-shareholder dynamics, since family-office capital often comes with bespoke structuring rather than standardized venture terms.